Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02939287 · OUTCOME

Complete Response (CR)

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan · Source last updated 2024-10-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
within 120 hours following melphalan administration; no emesis and no rescue therapy within 120 hours of melphalan administration (within 120 hours following last day of melphalan administration at baseline)

What was measured

no emesis and no rescue anti-emetic therapy

Groups in this outcome

Aprepitant

aprepitant plus standard anti-emetic regimen Aprepitant: Add aprepitant to anti-emetic regimen

Olanzapine

olanzapine plus standard anti-emetic regimen Olanzapine: add olanzapine to anti-emetic regimen

Aprepitant Plus Olanzapine

aprepitant and olanzapine plus standard anti-emetic regimen Aprepitant plus Olanzapine: add aprepitant and olanzapine to anti-emetic regimen

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Aprepitant14
Olanzapine21
Aprepitant Plus Olanzapine8

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Aprepitant4Not reportedNot reportedNot reportedNot reported
Olanzapine11Not reportedNot reportedNot reportedNot reported
Aprepitant Plus Olanzapine4Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        4
      2. group Id
        OG001
        value
        11
      3. group Id
        OG002
        value
        4
denoms
  1. counts
    1. group Id
      OG000
      value
      14
    2. group Id
      OG001
      value
      21
    3. group Id
      OG002
      value
      8
    units
    Participants
description
no emesis and no rescue anti-emetic therapy
groups
  1. description
    aprepitant plus standard anti-emetic regimen Aprepitant: Add aprepitant to anti-emetic regimen
    id
    OG000
    title
    Aprepitant
  2. description
    olanzapine plus standard anti-emetic regimen Olanzapine: add olanzapine to anti-emetic regimen
    id
    OG001
    title
    Olanzapine
  3. description
    aprepitant and olanzapine plus standard anti-emetic regimen Aprepitant plus Olanzapine: add aprepitant and olanzapine to anti-emetic regimen
    id
    OG002
    title
    Aprepitant Plus Olanzapine
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
within 120 hours following melphalan administration; no emesis and no rescue therapy within 120 hours of melphalan administration (within 120 hours following last day of melphalan administration at baseline)
title
Complete Response (CR)
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice